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Lean body mass (LBM) and age at menarche (AAM) are two important complex traits for human health. The aim of this study 
was to identify pleiotropic genes for both traits using a powerful bivariate genome-wide association study (GWAS). Two stud-
ies, a discovery study and a replication study, were performed. In the discovery study, 909622 single nucleotide polymor-
phisms (SNPs) were genotyped in 801 unrelated female Han Chinese subjects using the Affymetrix human genome-wide SNP 
array 6.0 platform. Then, a bivariate GWAS was performed to identify the SNPs that may be important for LBM and AAM. In 
the replication study, significant findings from the discovery study were validated in 1692 unrelated Caucasian female subjects. 
One SNP rs3027009 that was bivariately associated with left arm lean mass and AAM in the discovery samples (P=7.26×106) 
and in the replication samples (P=0.005) was identified. The SNP is located at the upstream of DARC (Duffy antigen receptor 
for chemokines) gene, suggesting that DARC may play an important role in regulating the metabolisms of both LBM and 
AAM. 
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Skeletal muscle is an important organ for human health. 
Loss and functional impairment of skeletal muscle predis-
pose individuals to a series of severe disorders, such as sar-
copenia, osteoporotic fracture, obesity, impaired protein 
balance, dyslipidemia, insulin resistance, and increased 
mortality [1,2]. Skeletal muscle was measured by lean body 
mass (LBM) [3], which is the best index for sarcopenia. 
LBM is a highly inheritable trait, with estimated heritability 
ranging from 52% to 84% [4–6]. Several candidate loci 
and/or genes have been identified for LBM. Among them, 
the gene GREMLIN1 at 15q13.3 was reported by Wang et al. 
[7] to be linked with LBM through genome-wide linkage 
studies. Liu et al. [8] identified the gene TRHR at 8q23.1 
and found that it was associated with LBM also through 
genome-wide association studies (GWAS). 
Menarche is the first menstrual cycle in females. It sig-
nals the sexual maturation and fertility of a woman. Age at 
menarche (AAM) is an important complex trait for wom-
en’s health. AAM is associated with a variety of complex 
diseases, including breast and endometrial cancer [9], Alz-
heimer’s disease [10], osteoporosis [11,12], and heart dis-
ease [13]. AAM is under strong genetic determination. 
There are highly significant correlations between AAM in 
mothers and daughters [14], and family history is a strong 
predictor for early menarche. The estimated heritability for 
AAM ranges from 50% to 70% [15–18]. Several candidate 
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genes have been suggested to influence AAM, such as an-
drogen receptor (AR), estrogen receptor alpha (ER-a) and 
beta (ER-b) [19–21], vitamin D receptor (VDR), sex hor-
mone binding globulin (SHBG) [22], insulin-like growth 
factor 1 (IGF-1) [23], chemokine (C-C-motif) receptor 3 
(CCR3) [24], and the CYP gene family [25–27]. 
Despite these findings, the genetic background underly-
ing both LBM and AAM remains largely unknown. This 
lack of knowledge is partially because of the limited statis-
tical power of the small sample sizes and locus effects. Al-
ternative analytical approaches with improved power are 
needed to help identify additional responsible loci. Both 
LBM and AAM are regulated by sex hormones, and humor-
al and cellular factors. Therefore, these two traits may share 
common genetic determinants. In the presence of such plei-
otropic genes, bivariate analysis, which can analyze the two 
traits jointly [28], is an alternative analytical approach to the 
existing univariate ones. By explicitly modeling genetic and 
environmental correlations between traits, bivariate analysis 
can theoretically extract more information from the data, 
consequently providing the test with greater power [29]. 
Thus, it is of great interest to study LBM and AAM using 
bivariate analysis with the purpose of identifying potential 
pleiotropic genes for both traits. 
With this aim, we performed a bivariate GWAS of the 
LBM and AAM traits. Using the Affymetrix human SNP 
6.0 array, we successfully genotyped and analyzed ~900000 
SNPs in 801 unrelated female Han Chinese subjects. We 
replicated the significant findings in another sample of 1692 
unrelated Caucasian female subjects. Through bivariate 
association analyses, we identified Duffy antigen receptor 
for chemokines (DARC) as a potential pleiotropic gene un-
derlying both LBM and AAM. 
1  Materials and methods 
1.1  Subjects 
1.1.1  The discovery GWAS subjects 
The discovery study sample consisted of 825 unrelated fe-
male Han Chinese subjects, living in the cities and neigh-
boring areas of Changsha and Xi’an in China. The study 
was approved by the Changsha and Xi’an institutional re-
view boards. After signing an informed consent, all subjects 
received assistance in completing a structured questionnaire 
that included questions regarding anthropometric variables, 
lifestyle, diet, family information, and medical history. 
Detailed medical information, such as menstrual history, 
was recorded using a nurse-administered questionnaire. 
AAM was calculated as the date of menarche minus the date 
of birth (in years, rounded to the first decimal place). The 
AAM followed approximately a normal distribution as veri-
fied by the Kolmogorov-Smirnov test with the software 
Minitab (Minitab, Inc., State College, PA, USA). 
Lean mass was measured using a dual-energy X-ray ab-
sorptiometry (DXA) scanner Hologic QDR 4500W (Holog-
ic Inc., Bedford, MA, USA), following the manufacturer’s 
protocol. A DXA scan can accurately measure total body 
and regional bone mass, fat mass, and fat-free mass. Lean 
mass was calculated by subtracting bone mass from fat-free 
mass. After removal of all metals, the subject lay on a bed 
and was scanned from head to toe. Whole body and 
sub-region compositions, such as head, trunk, and limb, 
were measured by the DXA scanner. To ensure the quality 
of collected data, all scans were conducted, reviewed, and 
analyzed by a clinical expert. Body weight, height, and age 
were obtained on the same visit. In this study, lean limb 
mass was analyzed. 
After excluding subjects with missing values for either 
the AAM or LBM phenotypes, the final sample that was 
used in the association analysis consisted of 801 unrelated 
Chinese female subjects. 
1.1.2  The replication GWAS subjects 
Significant findings from the discovery study were validat-
ed in a replication study. The replication sample consisted 
of 1728 female subjects of a Caucasian population recruited 
from the cities and neighboring areas of Omaha, NE and 
Kansas, MO, in the US. The recruitment was approved by 
the Institutional Review Boards of Creighton University and 
the University of Missouri-Kansas City. Signed informed 
consent documents were obtained from all study partici-
pants before they entered the study. 
In the replication subjects, the AAM and LBM were both 
measured in the same way as in the discovery subjects. Af-
ter excluding subjects with missing phenotypes, the sample 
size for data analysis was 1692. 
1.2  Genome-wide genotyping and quality controls 
1.2.1  Discovery sample 
Genomic DNA was extracted from peripheral blood leuko-
cytes using standard protocols. The Affymetrix genome-      
wide human SNP array 6.0 (Affymetrix, Santa Clara, CA, 
USA), which includes 906600 SNPs and 940000 copy 
number probes, was used to genotype the SNPs in the ge-
nome of each of the subjects, according to the manufactur-
er’s protocol. Briefly, approximately 250 ng of genomic 
DNA was digested with a restriction enzyme, either Nsp I or 
Sty I. The digested DNA from each sample was adaptor-       
ligated and PCR-amplified. The PCR products were labeled 
with biotin, denatured, and hybridized to the arrays. Arrays 
were then washed and stained using phycoerythrin on an 
Affymetrix Fluidics Station, and scanned using the 
GeneChip Scanner 3000 7G to quantitate fluorescence in-
tensities. Data management and analyses were conducted 
using the Genotyping Command Console. Only samples 
with a minimum call rate of 95% were included. Because 
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repeated experiments were performed, all of the subjects 
(n=801) met this criteria and the final mean call rate reached 
the high level of 98.93%. 
1.2.2  Replication sample 
Genotyping of the replication samples was also performed 
using the Affymetrix SNP 6.0 genotyping array following 
the same protocols as those described in Section 1.2.1 for 
the discovery samples. All of the subjects (n=1692) met the 
95% minimum call rate criterion and the final mean call rate 
reached the high level of 98.22%. 
1.3  Statistical analyses 
For each AAM and lean mass measurement, a stepwise re-
gression analysis was performed to screen the covariate 
effects of age, age2, height, and weight. Age was significant 
for AAM, while age, height, and weight were significant for 
lean mass (P<0.05). The significant covariates were used to 
adjust the raw phenotype values. 
To correct for potential population stratification, we per-
formed principal component analysis (PCA) on the ge-
nome-wide SNP data with EIGENSTRAT [30]. The top 
five principal components (PCs) were used to adjust the 
phenotype to minimize the effect of population stratifica-
tion. 
In the discovery sample, the association analyses be-
tween genotype and the two adjusted phenotypes were per-
formed with a bivariate linear regression model. The model 
can be represented as 
,i i ix  y     
where yi is the vector of the two phenotypes for individual i; 
 is the vector of grand means; xi is the genotype score for 
individual i, and  is the vector of its effects. Finally, i is 
the vector of residues following a multivariate normal dis-
tribution with mean zero. The genotype score xi was encod-
ed with an additive mode of inheritance. The association 
was examined by testing  from zero, and the test was per-
formed with the linear regression model in R package lm. 
For comparison purposes, we also performed univariate 
association analyses for the tested phenotypes, using the 
univariate linear regression model in the same R package 
lm. 
In the replication sample, SNPs that were suggestively 
associated with the AAM and LBM phenotypes (P<1×105) 
were further tested for association. To quantify the overall 
evidence of association achieved in the discovery and repli-
cation samples, Fisher’s method was used to combine the 
two individual P-values. 
2  Results 
The basic phenotypic characteristics of the subjects in the 
discovery and replication samples are listed in Table 1. In 
the discovery sample, a total of 44 SNPs had suggestive 
bivariate association signals (P<1×105). One of the SNPs, 
rs3027009, was also found to be significant in the replica-
tion sample; for the AAM and left-arm lean mass pheno-
types, P=7.26×106 in the discovery sample, and P=0.005 in 
the replication sample (Table 2). 
The SNP rs3027009 is located 1.2 kb upstream from the 
Duffy blood group, chemokine receptor (DARC) gene. 
Compared with the bivariate associations for this SNP, the 
univariate associations had much higher P-values, although 
they were significant (Table 2) too at the nominal level 0.05. 
The combined bivariate P-value was 7.14×107, close to the 
genome-wide significance level (Table 2). 
3  Discussion 
Here, we performed the first genome-wide bivariate associ- 
Table 1  Basic characteristics of the study subjectsa) 
 Discovery Replication 
Trait n=801 n=1692 
Age (years) 37.68 (13.83) 51.59 (12.92) 
Height (cm) 158.34 (5.21) 163.28 (6.27) 
Weight (kg) 54.68 (8.17) 71.45 (16.04) 
Left-arm lean (kg) 1.74 (0.32) 2.34 (0.52) 
Right-arm lean (kg) 1.91 (0.37) 2.47 (0.53) 
Left-leg lean (kg) 6.01 (0.79) 7.64 (1.37) 
Right-leg lean (kg) 6.09 (0.82) 7.76 (1.39) 
Age at menarche (years) 13.91 (1.61) 12.92 (1.58) 
a) Data are presented as mean (SD). 
Table 2  Characteristics of SNP rs3027009a) 




LA lean AAM LA lean AAM 
Discovery 
rs3027009 1 159173887 A/G 
0.01 2.51×10 6.16×10  7.26×10 
Replication 0.08 0.64 1.45×10  5.45×10 
Combined  0.01 1.33×10  7.14×10 
a) The univariate and bivariate association results are shown. Combined P-values were calculated using Fisher’s method. Chr, Chromosome; MAF, mi-
nor allele frequency; LA, left-arm; AAM, age at menarche. 
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ation study of LBM and AAM in a Chinese population 
sample. We further validated our findings in an additional 
Caucasian population sample. Our findings identified the 
DARC gene as a potential pleiotropic gene underlying both 
the LBM and AAM phenotypes. 
Genome-wide association studies have become a popular 
approach because of their superior resolution compared 
with linkage studies. With the high levels of phenotypic 
correlations among many diseases and traits, adequate at-
tentions should be given to multivariate approaches. How-
ever, compared with the fruitful methodological develop-
ments that have taken place in linkage studies, theoretical 
research in association studies is quite rare. Previously, 
Lange et al. [31] applied a generalized estimating equation 
(GEE) based approach to multivariate association analyses 
in pedigrees. Liu et al. [32] developed a population-based 
bivariate traits (one quantitative and one qualitative) associ-
ation analysis and Pei et al. [33] developed a multivariate 
haplotype-trend association method. Zhang et al. [29] ex-
tended the GEE-based method to data containing a mixture 
of unrelated and familial subjects. However, the application 
of these methods to experimental data has not been well 
recognized. In a previous study, Liu et al. [34] performed 
the first genome-wide bivariate association studies on obe-
sity and osteoporosis. The associated gene that they identi-
fied, SOX6, has been replicated by later studies, indicating 
the efficacy of their bivariate analyses. 
SNP rs3027009 that we found to be associated with 
LBM and AAM is located upstream of the DARC gene. The 
gene encodes a transmembrane glycoprotein of 35 kD with 
336 amino acid residues. The protein was first reported by 
Cutbush et al. [35] to act as a chemokine receptor. DARC 
has been reported to be closely associated with a variety of 
human disorders, such as malaria [36], tumors [37], and 
AIDS [38], and some of the latest studies have suggested 
that DARC influences the growth and transformation of tu-
mors through regulating the generation of tumor-relevant 
veins [37]. Edderkaoui et al. [39] reported that polymor-
phisms in the mouse DARC gene changed bone mineral 
density and influenced the risk to osteoporosis. Considering 
the high correlation between lean mass and bone mineral 
density, DARC may play a role in lean mass metabolism, 
though this relationship has not been reported previously. 
Our findings imply, for the first time, that the DARC gene is 
associated with LBM; however, the pathway through which 
DARC may regulate lean mass is unknown. The DARC pro-
tein is the main immune molecule on the surface of red 
blood cells [40]. Thus, we hypothesize that DARC affects 
the formation of the microvascular system in muscle tissue, 
which in turn affects the ingestion of the protein required 
for the synthesis of muscle. 
Menarche is the signal of the sexual maturation and fer-
tility in females. The process is controlled by the hypotha-
lamic-pituitary-ovarian axis, and is related to the release of 
gonadotropin and estrogen. It was reported previously that 
the estrogen receptor (ER) genes and the vitamin D receptor 
(VDR) gene were associated with AAM [19,21]. DARC and 
the ERs are closely related. Wang et al. [41] reported that 
the expressions of DARC and that of the ERs are positively 
correlated in breast cancer tissue. Therefore, though direct 
evidence is still lacking, we hypothesize that DARC may 
influence AAM by its chemotaxis effect on the estrogen 
receptor pathway. 
In summary, using a novel bivariate GWAS approach, 
we identified a gene, DARC, which may be important for 
both LBM and AAM. Replication of the association find-
ings in the Caucasian sample confirmed the association. The 
DARC gene has potential functional implications in both the 
formation of skeletal muscle and in the regulation of the 
estrogen receptor, and may be an important pleiotropic gene 
of LBM and AAM. Further investigations are needed to 
study the biological function of DARC and to replicate the 
findings in larger-scale studies. 
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